NI
BIO icon

Numeric Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Numeric Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,500
Closed -$333K – 1062
2017
Q3 		$333K Sell
1,500
-1,000
-40% -$225K ﹤0.01% 964
2017
Q2 		$566K Sell
2,500
-700
-22% -$153K 0.01% 793
2017
Q1 		$638K Buy
+3,200
New +$616K 0.01% 738
2014
Q3 		– Sell
-3,190
Closed -$382K – 818
2014
Q2 		$382K Buy
+3,190
New +$390K 0.01% 618
2014
Q1 		– Sell
-3,620
Closed -$447K – 785
2013
Q4 		$447K Buy
+3,620
New +$441K 0.01% 627

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Numeric Investors's BIO Position: Q4 2017 in Review

Numeric Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2017, closing a stake of 1,500 shares — an estimated $333K sold.

Numeric Investors first reported a position in BIO in Q4 2013 and held it in 5 quarters. The position peaked at $638K in Q1 2017. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

  • Numeric Investors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 1,500 Bio-Rad Laboratories Class A shares in Q4 2017, an estimated $333K.
  • Numeric Investors first reported a position in Bio-Rad Laboratories Class A in Q4 2013 and held it in 5 quarters.
  • Numeric Investors's Bio-Rad Laboratories Class A position peaked at $638K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.